The group around Mikiko Sodeoka has found that an O-derivative of nitro benzoxadiazole (NBD) which becomes fluorescent only after binding to a target membrane protein.
RIKEN news release, December 16, 2013
RIKEN researchers develop new affinity label for membrane protein directed drug targeting